Even mild forgetfulness can signal early cognitive decline—but it’s not too late to act.
At Alzheimer’s Treatment Centers of America (ATCA), we help people with mild cognitive impairment (MCI) improve memory, focus and quality of life using precision medicine boosted by enhanced technologies and cutting-edge brain therapies.
Cognitive decline can often be slowed—or even stopped—when treated early. That’s why it’s important to act early.
In an observational study of the AI protocols we use, 80% of patients with mild cognitive impairment experienced no further decline after starting care.
That means more clarity, confidence and control over your future.
We use advanced diagnostic tools powered by artificial intelligence built on years of medical practice and knowledge and brain mapping (BEAM™) to uncover the root causes of your symptoms—then build a personalized treatment plan that targets them directly.
Our leading therapies include:

Clears toxins, metals, and inflammation from your bloodstream.

Boosts brain energy and focus naturally.

Restores circulation and cellular balance for better brain function.

A breakthrough antibody treatment reducing brain inflammation and plaque buildup.

Delivers antioxidants and NAD+ directly to the brain for sharper memory.

Restores natural deep sleep cycles essential for memory and cellular repair.
Every plan is custom-built to your biology and goals.



We’re redefining what’s possible in brain health with over 50+ proven treatment modalities, from AI-guided protocols to innovative therapies that promote healing and regeneration.
You don’t have to wait until things get worse.
Take action now—because your brain deserves the best care possible.
Your memory and focus can improve.
Hope starts here—with science that works and care that listens.